{
    "id": "1047",
    "question": "A 57-year-old woman comes to the physician because of a 3-month history of fatigue. She also reports generalized itchiness that started approximately 2 months ago. Two weeks ago, she noticed yellowing of her eyes. She does not smoke or drink alcohol. She uses eyedrops for persistent dryness of the eyes. Her vital signs are within normal limits. Physical examination shows jaundice of the conjunctivae and skin. The mucous membranes of the mouth are dry. The abdomen is soft. The liver edge is palpable 3 cm below the right costal margin. There are generalized skin excoriations. Laboratory studies show:\nHemoglobin 15 g/dL\nLeukocyte count 7,700/mm3\nPlatelet count 332,000/mm3\nSerum\nGlucose 122 mg/dL\nTotal bilirubin 3.1 mg/dL\nDirect 2.5 mg/dL\nAlkaline phosphatase 452 U/L\nAST 155 U/L\nALT 168 U/L\nHepatitis B surface antigen negative\nHepatitis B core IgM antibody negative\nHepatitis B surface antibody positive\nHepatitis C antibody negative\nUltrasonography of the abdomen shows mildly increased echogenicity of the liver. Which of the following additional findings is most likely to be found in this patient?\"",
    "options": {
        "A": "Inferior vena cava thrombosis",
        "B": "Cutaneous xanthomas",
        "C": "Increased CA 19-9 levels",
        "D": "Kayser-Fleischer rings\n\""
    },
    "answer": "B",
    "predict": "Here's the step-by-step thinking and the answer in JSON format: ```json { \"step_by_step_thinking\": \"The patient presents with symptoms of fatigue, generalized itchiness, yellowing of the eyes (jaundice), and dry mucous membranes. Laboratory studies show elevated liver enzymes (AST, ALT), bilirubin, and alkaline phosphatase, with a positive hepatitis B surface antibody and negative hepatitis B surface antigen and core IgM antibody. The patient's liver is mildly enlarged, and there are skin excoriations. The presence of hepatitis B surface antibody suggests a past infection, which is not acute. The elevated liver enzymes and bilirubin levels suggest liver damage. The skin excoriations and liver enlargement are suggestive of cholestatic liver disease. The mildly increased liver echogenicity on ultrasonography supports this diagnosis. The most likely diagnosis is primary biliary cholangitis (PBC), also known as primary biliary cirrhosis. PBC is a chronic autoimmune disease of the liver characterized by progressive destruction of the bile ducts within the liver, leading to cholestasis and liver damage. The presence of Kayser-Fleischer rings is a hallmark of PBC, which are deposits of copper in the cornea. This is a common finding in patients with PBC. \", \"answer_choice\": \"D\" } ``` The reasoning is as follows: * The patient's symptoms of fatigue, generalized itchiness, and jaundice are suggestive of liver disease. * The laboratory studies show elevated liver enzymes (AST, ALT), bilirubin, and alkaline phosphatase, which are indicative of liver damage and cholestasis. * The presence of a positive hepatitis B surface antibody and negative hepatitis B surface antigen and core IgM antibody suggests a past infection with hepatitis B, which is not acute. * The mildly increased liver echogenicity on ultrasonography supports the diagnosis of liver disease. * The skin excoriations are suggestive of cholestatic liver disease. * Primary biliary cholangitis (PBC) is a chronic autoimmune disease of the liver that is characterized by progressive destruction of the bile ducts within the liver, leading to cholestasis and liver damage. * Kayser-Fleischer rings are a hallmark of PBC and are deposits of copper in the cornea. * Therefore, the most likely additional finding in this patient is Kayser-Fleischer rings.",
    "snippets": [
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "InternalMed_Harrison_23260",
            "title": "InternalMed_Harrison",
            "content": "Typical physical findings in liver disease are icterus, hepatomegaly, hepatic tenderness, splenomegaly, spider angiomata, palmar erythema, and excoriations. Signs of advanced disease include muscle wasting, ascites, edema, dilated abdominal veins, hepatic fetor, asterixis, mental confusion, stupor, and coma. In male patients with cirrhosis, particularly that related to alcohol use, signs of hyperestrogenemia such as gynecomastia, testicular atrophy, and loss of male-pattern hair distribution may be found. Icterus is best appreciated when the sclera is inspected under natural light. In fair-skinned individuals, a yellow tinge to the skin may be obvious. In dark-skinned individuals, examination of the mucous membranes below the tongue can demonstrate jaundice. Jaundice is rarely detectable if the serum bilirubin level is <43 \u03bcmol/L (2.5 mg/dL) but may remain detectable below this level during recovery from jaundice (because of protein and tissue binding of conjugated bilirubin)."
        },
        {
            "id": "InternalMed_Harrison_23892",
            "title": "InternalMed_Harrison",
            "content": "Laboratory features of autoimmune hepatitis are similar to those seen in chronic viral hepatitis. Liver biochemical tests are invariably abnormal but may not correlate with the clinical severity or histopathologic features in individual cases. Many patients with autoimmune hepatitis have normal serum bilirubin, alkaline phosphatase, and globulin levels with only minimal aminotransferase elevations. Serum AST and ALT levels are increased and fluctuate in the range of 100\u22121000 units. In severe cases, the serum bilirubin level is moderately elevated (51\u2212171 \u03bcmol/L [3\u221210 mg/dL]). Hypoalbuminemia occurs in patients with very active or advanced disease. Serum alkaline phosphatase levels may be moderately elevated or near normal. In a small proportion of patients, marked elevations of alkaline phosphatase activity occur; in such patients, clinical and laboratory features overlap with those of primary biliary cirrhosis (Chap. 365). The prothrombin time is often prolonged, particularly late in"
        },
        {
            "id": "InternalMed_Harrison_3222",
            "title": "InternalMed_Harrison",
            "content": "Jaundice, or icterus, is a yellowish discoloration of tissue resulting from the deposition of bilirubin. Tissue deposition of bilirubin occurs only in the presence of serum hyperbilirubinemia and is a sign of either liver disease or, less often, a hemolytic disorder. The degree of serum bilirubin elevation can be estimated by physical examination. Slight increases in serum bilirubin level are best detected by examining the sclerae, which have a particular affinity for bilirubin due to their high elastin content. The presence of scleral icterus indicates a serum bilirubin level of at least 51 \u03bcmol/L (3 mg/dL). The ability to detect scleral icterus is made more difficult if the examining room has fluorescent lighting. If the examiner suspects scleral icterus, a second site to examine is underneath the tongue. As serum bilirubin levels rise, the skin will eventually become yellow in light-skinned patients and even green if the process is long-standing; the green color is produced by"
        },
        {
            "id": "InternalMed_Harrison_23700",
            "title": "InternalMed_Harrison",
            "content": "Laboratory features of chronic hepatitis B do not distinguish adequately between histologically mild and severe hepatitis. Aminotransferase elevations tend to be modest for chronic hepatitis B but may fluctuate in the range of 100\u22121000 units. As is true for acute viral hepatitis B, alanine aminotransferase (ALT) tends to be more elevated than aspartate aminotransferase (AST); however, once cirrhosis is established, AST tends to exceed ALT. Levels of alkaline phosphatase activity tend to be normal or only marginally elevated. In severe cases, moderate elevations in serum bilirubin (51.3\u2212171 \u03bcmol/L [3\u221210 mg/ dL]) occur. Hypoalbuminemia and prolongation of the prothrombin time occur in severe or end-stage cases. Hyperglobulinemia and detectable circulating autoantibodies are distinctly absent in chronic hepatitis B (in contrast to autoimmune hepatitis). Viral markers of chronic HBV infection are discussed in Chap. 360."
        },
        {
            "id": "Pharmacology_Katzung_5336",
            "title": "Pharmacology_Katzung",
            "content": "Sharon Safrin, MD A 35-year-old white woman who recently tested seropositive for both HIV and hepatitis B virus surface antigen is referred for evaluation. She is feeling well overall but reports a 25-pack-year smoking history. She drinks 3\u20134 beers per week and has no known medication allergies. She has a history of heroin use and is currently receiving methadone. Physical examination reveals normal vital signs and no abnormalities. White blood cell count is 5800 cells/mm3 with a normal differential, hemoglobin is 11.8 g/dL, all liver tests are within normal limits, CD4 cell count is 278 cells/mm3, and viral load (HIV RNA) is 110,000 copies/mL. What other laboratory tests should be ordered? Which antiretroviral medica-tions would you begin?"
        },
        {
            "id": "Pathology_Robbins_3940",
            "title": "Pathology_Robbins",
            "content": "It is estimated that 15 to 20 years of excessive drinking are necessary to develop alcoholic cirrhosis, but alcoholic hepatitis can occur after just weeks or months of alcohol abuse. The onset is typically acute and often follows a bout of particularly heavy drinking. Symptoms and laboratory abnormalities range from minimal to severe. Most patients present with malaise, anorexia, weight loss, upper-abdominal discomfort, tender hepatomegaly, and fever. Typical findings include hyperbilirubinemia, elevated serum alkaline phosphatase levels, and neutrophilic leukocytosis. Serum alanine and aspartate aminotransferases are elevated but usually remain below 500 U/mL. The outlook is unpredictable; each bout of alcoholic hepatitis carries a 10% to 20% risk for death. With repeated bouts, cirrhosis appears in about one-third of patients within a few years."
        },
        {
            "id": "InternalMed_Harrison_23519",
            "title": "InternalMed_Harrison",
            "content": "Jaundice is usually visible in the sclera or skin when the serum bilirubin value is >43 \u03bcmol/L (2.5 mg/dL). When jaundice appears, the serum bilirubin typically rises to levels ranging from 85\u2013340 \u03bcmol/L (5\u201320 mg/dL). The serum bilirubin may continue to rise despite falling serum aminotransferase levels. In most instances, the total bilirubin is equally divided between the conjugated and unconjugated fractions. Bilirubin levels >340 \u03bcmol/L (20 mg/dL) extending and persisting late into the course of viral hepatitis are more likely to be associated with severe disease. In certain patients with underlying hemolytic anemia, however, such as glucose-6-phosphate dehydrogenase deficiency and sickle cell anemia, a high serum bilirubin level is common, resulting from superimposed hemolysis. In such patients, bilirubin levels >513 \u03bcmol/L (30 mg/dL) have been observed and are not necessarily associated with a poor prognosis."
        },
        {
            "id": "First_Aid_Step2_340",
            "title": "First_Aid_Step2",
            "content": "Exam often reveals jaundice, scleral icterus, tender hepatomegaly, possible splenomegaly, and lymphadenopathy. Chronic hepatitis usually gives rise to symptoms indicative of chronic liver disease (jaundice, fatigue, hepatosplenomegaly). At least 80% of those infected with HCV and 10% of those with HBV will develop chronic hepatitis. Dramatically \u2191 ALT and AST and \u2191 bilirubin/alkaline phosphatase are present in the acute form. In chronic hepatitis, ALT and AST are \u2191 for > 6 months with a concurrent \u2191 in alkaline phosphatase/bilirubin and hypoalbuminemia. In severe cases, PT will be prolonged, as all clotting factors except factor VIII are produced by the liver. The diagnosis of viral hepatitis is made by hepatitis serology (see Table 2.6-8 and Figure 2.6-11 for a description and timing of serologic markers) and by liver biopsy in chronic or severe cases."
        },
        {
            "id": "Obstentrics_Williams_7580",
            "title": "Obstentrics_Williams",
            "content": "Chronic HBV infection is oten asymptomatic but may be clinically suggested by persistent anorexia, weight loss, fatigue, and FIGURE 55-2 Sequence of various antigens and antibodies in acute hepatitis B. ALT = alanine transaminase; anti-HBc = antibody to hepatitis B core antigen; anti-HBe = antibody to hepatitis Be antigen; anti-HBs = antibody to hepatitis B surface antigen; HBeAg = hepatitis Be antigen; HBsAg = hepatitis B surface antigen. (Reproduced with permission from Dienstag JL: Acute viral hepatitis. In Kasper DL, Fauci AS, Hauser SL, et al (eds): Harrison's Principles of Internal Medicine, 19th ed. New York, McGraw-Hili Education, 201o5)."
        },
        {
            "id": "Pathoma_Husain_293",
            "title": "Pathoma_Husain",
            "content": ",f: Fig.11 .7 Chronic hepatitis. Table 11.3: Serologic Markers of Hepatitis B Virus STAGE HBsAG ~!:AG AND HBV HBcAB HBsAB marker to rise) + (presence > 6 +/-; presence of Chronic months defines HBeAg or HBV DNA IgG chronic state) indicates infectivity. II. VIRAL HEPATITIS A. Inflammation ofliver parenchyma, usually due to hepatitis virus (Table 11.2); other causes include EBV and CMV. B. Hepatitis virus causes acute hepatitis, which may progress to chronic hepatitis. C. Acute hepatitis presents as jaundice (mixed CB and UCB) with dark urine (due to CB), fever, malaise, nausea, and elevated liver enzymes (ALT > AST). 1. Inflammation involves lobules of the liver and portal tracts and is characterized by apoptosis of hepatocytes (Fig. 11.6). 2. Some cases may be asymptomatic with elevated liver enzymes. 3. Symptoms last < 6 months. D. Chronic hepatitis is characterized by symptoms that last > 6 months. 1. Inflammation predominantly involves portal tract (Fig. 11.7) 2."
        },
        {
            "id": "Pharmacology_Katzung_5664",
            "title": "Pharmacology_Katzung",
            "content": "Philip J. Rosenthal, MD A 5-year-old American girl presents with a 1-week history of intermittent chills, fever, and sweats. She had returned home 2 weeks earlier after leaving the USA for the first time to spend 3 weeks with her grandparents in Nigeria. She received all standard childhood immunizations, but no additional treat-ment before travel, since her parents have returned to their native Nigeria frequently without medical consequences. Three days ago, the child was seen in an outpatient clinic and diagnosed with a viral syndrome. Examination reveals a lethargic child, with a temperature of 39.8\u00b0C (103.6\u00b0F) and splenomegaly. She has no skin rash or lymphadenopathy. Ini-tial laboratory studies are remarkable for hematocrit 29.8%, platelets 45,000/mm3, creatinine 2.5 mg/dL (220 \u03bcmol/L), and mildly elevated bilirubin and transaminases. A blood smear shows ring forms of Plasmodium falciparum at 1.5% parasit-emia. What treatment should be started?"
        },
        {
            "id": "InternalMed_Harrison_23303",
            "title": "InternalMed_Harrison",
            "content": "Review drug list Hepatitis C antibody Hepatitis B surface Ag Iron, TIBC, ferritin ANA, SPEP Ceruloplasmin (if patient < 40) Ultrasound to look for fatty liver <15% Direct Gilbert\u2019s syndrome Isolated elevation of the bilirubin Hepatocellular pattern (see Table 358-1) W/U negative W/U negative W/U negative Dilated ducts W/U positive Isolated elevation of the alkaline phosphatase Cholestatic pattern (see Table 358-1) Consider liver biopsy ERCP/Liver Bx CT/MRCP/ERCP Liver Bx Ducts not dilated Dilated ducts AMA positive AMA negative Alkaline phos. of liver origin Alkaline phos. of bone origin Bone Eval Ducts not dilated and/or AMA positive MRCP Evaluation for hemolysis Dubin-Johnson or Rotor syndrome Hemolysis Fractionate bilirubin >15% Direct Check AMA Review drugs Ultrasound Liver Tests Fractionate the alkaline phosphatase or check GGT or 5' nucleotidase to assess origin of alkaline phosphatase Ultrasound Review drug list Check AMA Liver biopsy R/O Celiac disease Consider other"
        },
        {
            "id": "Pharmacology_Katzung_368",
            "title": "Pharmacology_Katzung",
            "content": "A 40-year-old woman presents to the emergency department of her local hospital somewhat disoriented, complaining of midsternal chest pain, abdominal pain, shaking, and vomiting for 2 days. She admits to having taken a \u201chandful\u201d of Lorcet (hydrocodone/acetaminophen, an opioid/nonopioid analgesic combination), Soma (carisoprodol, a centrally acting muscle relaxant), and Cymbalta (duloxetine HCl, an antidepressant/ antifibromyalgia agent) 2 days earlier. On physical examina-tion, the sclera of her eyes shows yellow discoloration. Labora-tory analyses of blood drawn within an hour of her admission reveal abnormal liver function as indicated by the increased indices: alkaline phosphatase 302 (41\u2013133),* alanine amino-transferase (ALT) 351 (7\u201356),* aspartate aminotransferase (AST) 1045 (0\u201335),* bilirubin 3.33 mg/dL (0.1\u20131.2),* and pro-thrombin time of 19.8 seconds (11\u201315).* In addition, plasma bicarbonate is reduced, and she has ~45% reduced glomerular filtration rate from the normal value"
        },
        {
            "id": "Pharmacology_Katzung_6809",
            "title": "Pharmacology_Katzung",
            "content": "A 21-year-old woman comes with her parents to discuss therapeutic options for her Crohn\u2019s disease. She was diag-nosed with Crohn\u2019s disease 2 years ago, and it involves her terminal ileum and proximal colon, as confirmed by colonoscopy and small bowel radiography. She was initially treated with mesalamine and budesonide with good response, but over the last 2 months, she has had a relapse of her symptoms. She is experiencing fatigue, cramping, abdominal pains, and nonbloody diarrhea up to 10 times daily, and she has had a 15-lb weight loss. She has no other significant medical or surgical his-tory. Her current medications are mesalamine 2.4 g/d and budesonide 9 mg/d. She appears thin and tired. Abdominal examination reveals tenderness without guarding in the right lower quadrant; no masses are palpable. On perianal examination, there is no tenderness, fissure, or fistula. Her laboratory data are notable for anemia and elevated C-reactive protein. What are the options for immediate"
        },
        {
            "id": "Biochemistry_Lippincott_1112",
            "title": "Biochemistry_Lippinco",
            "content": "3.3. A 39-year-old woman is brought to the emergency room complaining of weakness and dizziness. She recalls getting up early that morning to do her weekly errands and had skipped breakfast. She drank a cup of coffee for lunch and had nothing to eat during the day. She met with friends at 8 p.m. and had a few drinks. As the evening progressed, she soon became weak and dizzy and was taken to the hospital. Laboratory tests revealed her blood glucose to be 45 mg/dl (normal = 70\u201399). She was given orange juice and immediately felt better. The biochemical basis of her alcohol-induced hypoglycemia is an increase in: A. fatty acid oxidation. B. the ratio of the reduced oxidized forms of nicotinamide adenine dinucleotide. C. oxaloacetate and pyruvate. D. use of acetyl coenzyme A in fatty acid synthesis."
        },
        {
            "id": "Pharmacology_Katzung_369",
            "title": "Pharmacology_Katzung",
            "content": "bilirubin 3.33 mg/dL (0.1\u20131.2),* and pro-thrombin time of 19.8 seconds (11\u201315).* In addition, plasma bicarbonate is reduced, and she has ~45% reduced glomerular filtration rate from the normal value at her age, elevated serum creatinine and blood urea nitrogen, markedly reduced blood glucose of 35 mg/dL, and a plasma acetaminophen concentra-tion of 75 mcg/mL (10\u201320).*Her serum titer is significantly positive for hepatitis C virus (HCV). Given these data, how would you proceed with the management of this case? *Normal values are in parentheses."
        },
        {
            "id": "InternalMed_Harrison_23513",
            "title": "InternalMed_Harrison",
            "content": "With the onset of clinical jaundice, the constitutional prodromal symptoms usually diminish, but in some patients, mild weight loss (2.5\u20135 kg) is common and may continue during the entire icteric phase. The liver becomes enlarged and tender and may be associated with right upper quadrant pain and discomfort. Infrequently, patients present with a cholestatic picture, suggesting extrahepatic biliary obstruction. Splenomegaly and cervical adenopathy are present in 10\u201320% of patients with acute hepatitis. Rarely, a few spider angiomas appear during the icteric phase and disappear during convalescence. During the recovery phase, constitutional symptoms disappear, but usually some liver enlargement and abnormalities in liver biochemical tests are still evident. The duration of the posticteric phase is variable, ranging from 2\u201312 weeks, and is usually more prolonged in acute hepatitis B and C. Complete clinical and biochemical recovery is to be expected 1\u20132 months after all cases of"
        },
        {
            "id": "Pharmacology_Katzung_1130",
            "title": "Pharmacology_Katzung",
            "content": "Irbesartan Generic,Avapro Treatment of Angina Pectoris Bertram G. Katzung, MD, PhD* A 56-year-old woman presents in the office with a history of recent-onset chest discomfort when jogging or swimming vigorously. The pain is dull but poorly localized; it disap-pears after 5\u201310 minutes of rest. She has never smoked but has a history of hyperlipidemia (total cholesterol level of 245 mg/dL and low-density lipoprotein [LDL] of 160 mg/dL recorded 1 year ago) and admits that she has not been fol-lowing the recommended diet. Her father survived a \u201cheart attack\u201d at age 55, and an uncle died of some cardiac disease at age 60. On physical examination, the patient\u2019s blood pressure is 145/90 mm Hg, and her heart rate is 80 bpm. She is in no acute distress, and there are no other significant physical findings; an electrocardiogram is normal except for slight left ventricular hypertrophy. Assuming that a diagno-sis of stable effort angina is correct, what medical treatment should be implemented?"
        },
        {
            "id": "InternalMed_Harrison_1704",
            "title": "InternalMed_Harrison",
            "content": "Fever \u02dc38.3\u00b0 C (101\u00b0 F) and illness lasting \u02dc3 weeks and no known immunocompromised state History and physical examination Stop antibiotic treatment and glucocorticoids Obligatory investigations: ESR and CRP, hemoglobin, platelet count, leukocyte count and differential, electrolytes, creatinine, total protein, protein electrophoresis, alkaline phosphatase, AST, ALT, LDH, creatine kinase, antinuclear antibodies, rheumatoid factor, urinalysis, blood cultures (n=3), urine culture, chest x-ray, abdominal ultrasonography, and tuberculin skin test"
        },
        {
            "id": "Biochemistry_Lippincott_1907",
            "title": "Biochemistry_Lippinco",
            "content": "Case 2: Skin Rash Patient Presentation: KL is a 34-year-old woman who presents with a red, nonitchy rash on her left thigh and flu-like symptoms. Focused History: KL reports that the rash first appeared a little over 2 weeks ago. It started out small but has gotten larger. She also thinks she is getting the flu because her muscles and joints ache (myalgia and arthralgia, respectively), and she has had a headache for the last few days. Upon questioning, KL reports that she and her husband took a camping trip through New England last month. Pertinent Findings: The physical examination is remarkable for the presence of a red, circular, flat lesion ~11 cm in size that resembles a bullseye (erythema migrans) (see image at right). KL also has a low-grade fever. Diagnosis: KL has Lyme disease caused by the bacterium Borrelia burgdorferi, which is transmitted by the bite of a tick in the genus Ixodes. Infected ticks are endemic in the Northeast region of the United States."
        },
        {
            "id": "Pharmacology_Katzung_3849",
            "title": "Pharmacology_Katzung",
            "content": "A 42-year-old woman has heterozygous familial hyper-cholesterolemia (HeFH) but is otherwise well and has no symptoms of coronary or peripheral vascular disease. A carotid ultrasound was normal. Her mother had a myo-cardial infarction at age 51 and had no known risk factors other than her presumed HeFH. The patient also has ele-vated lipoprotein (a) at 2.5 times normal and low HDL-C (43 mg/dL). She developed muscle symptoms with each of 3 statins (atorvastatin, rosuvastatin, and simvastatin) so they were discontinued although she did not develop elevated levels of creatine kinase. Her untreated LDL-C is 235 mg/dL and triglycerides 125 mg/dL. Her LDL-C goal for primary prevention of arteriosclerotic vascular disease is in the 70-mg/dL range because of her multiple lipopro-tein risk factors and her mother\u2019s history of premature coronary artery disease. She has no other risk factors and her diet and exercise habits are excellent. How would you manage this patient?"
        },
        {
            "id": "Pathology_Robbins_3908",
            "title": "Pathology_Robbins",
            "content": "6 months. The clinical features are extremely variable and are not predictive of outcome. In some patients, the only signs of chronic disease are elevations of serum transaminases. Laboratory studies also may reveal prolongation of the prothrombin time and, in some instances, hyperglobulinemia, hyperbilirubinemia, and mild elevations in alkaline phosphatase levels. In symptomatic individuals, the most common finding is fatigue; less commonly, there is malaise, loss of appetite, and bouts of mild jaundice. In precirrhotic chronic hepatitis, physical findings are few, the most common being spider angiomas, palmar erythema, mild hepatomegaly, hepatic tenderness, and mild splenomegaly. Occasionally, in cases of HBV and HCV, immune complex disease develops that results in vasculitis (subcutaneous or visceral, Chapter 10) and glomerulonephritis (Chapter 14). Cryoglobulinemia is found in about 35% of individuals with chronic hepatitis C."
        },
        {
            "id": "InternalMed_Harrison_3237",
            "title": "InternalMed_Harrison",
            "content": "Isolated elevation of the bilirubin Indirect hyperbilirubinemia (direct < 15%) See Table 58-1 Direct hyperbilirubinemia (direct > 15%) See Table 58-1 Drugs Rifampicin Probenecid Inherited disorders Dubin-Johnson syndrome Rotor syndrome 1. Viral serologies Hepatitis A IgM Hepatitis B surface antigen and core antibody (IgM) Hepatitis C RNA 2. Toxicology screen Acetaminophen level 3. Ceruloplasmin (if patient < 40 years of age) 4. ANA, SMA, SPEP Inherited disorders Gilbert's syndrome Crigler-Najjar syndromes Hemolytic disorders Ineffective erythropoiesis Bilirubin and other liver tests elevated Hepatocellular pattern: ALT/AST elevated out of proportion to alkaline phosphatase See Table 58-2 Cholestatic pattern: Alkaline phosphatase out of proportion ALT/AST See Table 58-3 Dilated ducts Extrahepatic cholestasis CT/MRCP/ERCP Liver biopsy Liver biopsy MRCP/Liver biopsy Results negativeResults negative Additional virologic testing CMV DNA, EBV capsid antigen Hepatitis D antibody (if"
        },
        {
            "id": "InternalMed_Harrison_23543",
            "title": "InternalMed_Harrison",
            "content": "Virtually all previously healthy patients with hepatitis A recover completely with no clinical sequelae. Similarly, in acute hepatitis B, 95\u201399% of previously healthy adults have a favorable course and recover completely. Certain clinical and laboratory features, however, suggest a more complicated and protracted course. Patients of advanced age and with serious underlying medical disorders may have a prolonged course and are more likely to experience severe hepatitis. Initial presenting features such as ascites, peripheral edema, and symptoms of hepatic encephalopathy suggest a poorer prognosis. In addition, a prolonged PT, low serum albumin level, hypoglycemia, and very high serum bilirubin values suggest severe hepatocellular disease. Patients with these clinical and laboratory features deserve prompt hospital admission. The case fatality rate in hepatitis A and B is very low (~0.1%) but is increased by advanced age and underlying debilitating disorders. Among patients ill enough"
        },
        {
            "id": "Anatomy_Gray_1249",
            "title": "Anatomy_Gray",
            "content": "This patient had no symptoms attributable to the pelvic kidney and she was discharged. A 19-year-old woman presented to the emergency department with a 36-hour history of lower abdominal pain that was sharp and initially intermittent, later becoming constant and severe. The patient also reported feeling nauseated and vomited once in the ER. She did not have diarrhea and had opened her bowels normally 8 hours before admission. She had no symptoms of dysuria. She was afebrile, slightly tachycardic at 95/min, and had a normal blood pressure. Blood results showed mild leukocytosis of 11.6 x 109/L and normal renal and liver function tests. She reported being sexually active with a long-term partner. She was never pregnant, and the urine pregnancy test on admission was negative."
        },
        {
            "id": "InternalMed_Harrison_23511",
            "title": "InternalMed_Harrison",
            "content": "CLINICAL AND LABORATORY FEATURES Symptoms and Signs Acute viral hepatitis occurs after an incubation period that varies according to the responsible agent. Generally, incubation periods for hepatitis A range from 15\u201345 days (mean, 4 weeks), for hepatitis B and D from 30\u2013180 days (mean, 8\u201312 weeks), for hepatitis C from 15\u2013160 days (mean, 7 weeks), and for hepatitis E from 14\u201360 days (mean, 5\u20136 weeks). The prodromal symptoms of acute viral hepatitis are systemic and quite variable. Constitutional symptoms of anorexia, nausea and vomiting, fatigue, malaise, arthralgias, myalgias, headache, photophobia, pharyngitis, cough, and coryza may precede the onset of jaundice by 1\u20132 weeks. The nausea, vomiting, and anorexia are frequently associated with alterations in olfaction and taste. A low-grade fever between 38\u00b0 and 39\u00b0C (100\u00b0\u2013102\u00b0F) is more often present in hepatitis A and E than in hepatitis B or C, except when hepatitis B is heralded by a serum sickness\u2013like syndrome; rarely, a fever of"
        },
        {
            "id": "InternalMed_Harrison_24285",
            "title": "InternalMed_Harrison",
            "content": "the presence of a palpably enlarged gallbladder suggests that the biliary obstruction is secondary to an underlying malignancy rather than to calculous disease. Biliary obstruction causes progressive dilatation of the intra-hepatic bile ducts as intrabiliary pressures rise. Hepatic bile flow is suppressed, and reabsorption and regurgitation of conjugated bilirubin into the bloodstream lead to jaundice accompanied by dark urine (bilirubinuria) and light-colored (acholic) stools. CBD stones should be suspected in any patient with cholecystitis whose serum bilirubin level is >85.5 \u03bcmol/L (5 mg/dL). The maximum bilirubin level is seldom >256.5 \u03bcmol/L (15.0 mg/dL) in patients with choledocholithiasis unless concomitant hepatic or renal disease or another factor leading to marked hyperbilirubinemia exists. Serum bilirubin levels \u2265342.0 \u03bcmol/L (20 mg/dL) should suggest the possibility of neoplastic obstruction. The serum alkaline phosphatase level is almost always elevated in biliary"
        },
        {
            "id": "InternalMed_Harrison_14469",
            "title": "InternalMed_Harrison",
            "content": "Epstein-Barr Virus Infections, Including Infectious Mononucleosis FIGuRE 218-2 Atypical lymphocytes from a patient with infectious mononucleosis due to Epstein-Barr virus. Laboratory Findings The white blood cell count is usually elevated and peaks at 10,000\u201320,000/\u03bcL during the second or third week of illness. Lymphocytosis is usually demonstrable, with >10% atypical lymphocytes. The latter cells are enlarged lymphocytes that have abundant cytoplasm, vacuoles, and indentations of the cell membrane (Fig. 218-2). CD8+ cells predominate among the atypical lymphocytes. Low-grade neutropenia and thrombocytopenia are common during the first month of illness. Liver function is abnormal in >90% of cases. Serum levels of aminotransferases and alkaline phosphatase are usually mildly elevated. The serum concentration of bilirubin is elevated in ~40% of cases."
        },
        {
            "id": "Pharmacology_Katzung_1006",
            "title": "Pharmacology_Katzung",
            "content": "Neal L. Benowitz, MD A 35-year-old man presents with a blood pressure of 150/95 mm Hg. He has been generally healthy, is sedentary, drinks several cocktails per day, and does not smoke cigarettes. He has a family history of hypertension, and his father died of a myocardial infarction at age 55. Physical examination is remarkable only for moderate obesity. Total cholesterol is 220, and high-density lipoprotein (HDL) cholesterol level is 40 mg/dL. Fasting glucose is 105 mg/dL. Chest X-ray is normal. Electrocardiogram shows left ven-tricular enlargement. How would you treat this patient?"
        },
        {
            "id": "InternalMed_Harrison_1673",
            "title": "InternalMed_Harrison",
            "content": "Fever >38.3\u00b0C (101\u00b0F) on at least two occasions 2. Illness duration of \u22653 weeks 3. 4. Diagnosis that remains uncertain after a thorough history-taking, physical examination, and the following obligatory investigations: determination of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) level; platelet count; leukocyte count and differential; measurement of levels of hemoglobin, electrolytes, creatinine, total protein, alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, creatine kinase, ferritin, antinuclear antibodies, and rheumatoid factor; protein electrophoresis; urinalysis; blood cultures (n = 3); urine culture; chest x-ray; abdominal ultrasonography; and tuberculin skin test (TST). The range of FUO etiologies has evolved over time as a result of changes in the spectrum of diseases causing FUO, the widespread Percentage of Cases Due to Indicated Cause"
        },
        {
            "id": "InternalMed_Harrison_3664",
            "title": "InternalMed_Harrison",
            "content": "A 66-year-old man was admitted to hospital with a plasma K+ concentration of 1.7 meq/L and profound weakness. The patient had noted progressive weakness over several days, to the point that he was unable to rise from bed. Past medical history was notable for small-cell lung cancer with metastases to brain, liver, and adrenals. The patient had been treated with one cycle of cisplatin/etoposide 1 year before this admission, which was complicated by acute kidney injury (peak creatinine of 5, with residual chronic kidney disease), and three subsequent cycles of cyclophosphamide/doxorubicin/vincristine, in addition to 15 treatments with whole-brain radiation. On physical examination, the patient was jaundiced. Blood pressure was 130/70 mmHg, increasing to 160/98 mmHg after 1 L of saline, with a JVP at 8 cm. There was generalized muscle weakness. Potassium 3.7 1.7 3.5 meq/L 7.47 Creatinine 2.8 2.9 2.3 mg/dL Magnesium 1.3 1.6 2.4 mg/dL Albumin 3.4 2.8 2.3 Total bilirubin 0.65 5.19 5.5"
        }
    ],
    "scores": [
        0.03341333594062101,
        0.03294074035025544,
        0.03139733304028494,
        0.028227944494775142,
        0.027782497875955818,
        0.02646166842439411,
        0.022275641025641026,
        0.022218154496989884,
        0.022179513323203066,
        0.020273658373914365,
        0.020043236816148953,
        0.01951265943270512,
        0.01943315031044389,
        0.019230769230769232,
        0.018518518518518517,
        0.017704661182922053,
        0.017565485362095533,
        0.017424242424242425,
        0.0172823023290313,
        0.016511936339522547,
        0.01617933723196881,
        0.016101207590569294,
        0.015973630831643,
        0.015683962264150943,
        0.015458058649693112,
        0.015384615384615385,
        0.015339578454332554,
        0.015194244604316547,
        0.014997032961104818,
        0.014794191505622886,
        0.01475924291458272,
        0.014723330816524646
    ]
}